Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, October 21, 2009

Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel.

note: in 2 ovarian cancer patients (study)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.